BCWORLD PHARM Balance Sheet Health
Financial Health criteria checks 1/6
BCWORLD PHARM has a total shareholder equity of ₩75.1B and total debt of ₩86.2B, which brings its debt-to-equity ratio to 114.8%. Its total assets and total liabilities are ₩171.2B and ₩96.1B respectively. BCWORLD PHARM's EBIT is ₩432.3M making its interest coverage ratio 0.1. It has cash and short-term investments of ₩7.0B.
Key information
114.8%
Debt to equity ratio
₩86.24b
Debt
| Interest coverage ratio | 0.09x |
| Cash | ₩7.01b |
| Equity | ₩75.10b |
| Total liabilities | ₩96.08b |
| Total assets | ₩171.18b |
Recent financial health updates
BCWORLD PHARM (KOSDAQ:200780) Seems To Be Using A Lot Of Debt
Mar 01
Is BCWorld Pharm (KOSDAQ:200780) A Risky Investment?
Nov 18
Recent updates
Investors Shouldn't Be Too Comfortable With BCWORLD PHARM's (KOSDAQ:200780) Earnings
Mar 18BCWORLD PHARM (KOSDAQ:200780) Seems To Be Using A Lot Of Debt
Mar 01Does The Market Have A Low Tolerance For BCWORLD PHARM. Co., Ltd.'s (KOSDAQ:200780) Mixed Fundamentals?
Feb 09Is BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780) A Good Dividend Stock?
Jan 25If You Had Bought BCWorld Pharm (KOSDAQ:200780) Stock A Year Ago, You Could Pocket A 75% Gain Today
Jan 11Do Insiders Own Lots Of Shares In BCWorld Pharm Co., Ltd. (KOSDAQ:200780)?
Dec 26Are BCWorld Pharm's (KOSDAQ:200780) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 08Is BCWorld Pharm (KOSDAQ:200780) A Risky Investment?
Nov 18Financial Position Analysis
Short Term Liabilities: A200780's short term assets (₩38.8B) do not cover its short term liabilities (₩80.9B).
Long Term Liabilities: A200780's short term assets (₩38.8B) exceed its long term liabilities (₩15.2B).
Debt to Equity History and Analysis
Debt Level: A200780's net debt to equity ratio (105.5%) is considered high.
Reducing Debt: A200780's debt to equity ratio has increased from 63.6% to 114.8% over the past 5 years.
Debt Coverage: A200780's debt is not well covered by operating cash flow (8.3%).
Interest Coverage: A200780's interest payments on its debt are not well covered by EBIT (0.1x coverage).